Medicine Today, Money Tomorrow
How today’s Big Pharma will merge with tomorrow’s Big Finance
Gilead, a major Big Pharma company, is in a bit of a bind. Their problem? Sales of some of their key drugs are tanking. Why’s that? Because they work too well.
In 2013, the United States FDA approved Gilead’s new hepatitis C drug, Sovaldi. Immediately, patients who might otherwise…